Brexit: Interview with Richard Torbett

The video discusses the importance of medicines cooperation between the UK and the EU post-Brexit. It highlights the need for seamless access to medicines for patients and the significance of maintaining collaboration in drug approvals. The UK aims to remain competitive in the global pharmaceutical industry while ensuring high regulatory standards. The discussion also emphasizes the UK's substantial contribution to global drug development and the need for continuity and certainty for investors and scientists.

What new insight or understanding did you gain from this video?